Compare PBYI & FMAO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PBYI | FMAO |
|---|---|---|
| Founded | 2010 | 1897 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 364.9M | 397.1M |
| IPO Year | 2011 | 1996 |
| Metric | PBYI | FMAO |
|---|---|---|
| Price | $8.07 | $30.02 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $28.50 |
| AVG Volume (30 Days) | ★ 374.7K | 114.9K |
| Earning Date | 05-07-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 3.45% |
| EPS Growth | N/A | ★ 27.89 |
| EPS | N/A | ★ 0.70 |
| Revenue | ★ $27,685,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $6.20 |
| P/E Ratio | ★ N/A | $42.60 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.03 | $22.89 |
| 52 Week High | $8.44 | $32.00 |
| Indicator | PBYI | FMAO |
|---|---|---|
| Relative Strength Index (RSI) | 56.00 | 56.28 |
| Support Level | $6.50 | $25.94 |
| Resistance Level | $8.42 | $32.00 |
| Average True Range (ATR) | 0.41 | 0.86 |
| MACD | -0.02 | -0.11 |
| Stochastic Oscillator | 47.13 | 41.92 |
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also, it is developing Alisertib, a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis, resulting in apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
Farmers & Merchants Bancorp Inc is a holding company based in Ohio. The company is engaged in one segment which is commercial banking. The activities of the company include commercial, agricultural and residential mortgages as well as consumer and credit card lending activities.